Pesquisas alternativas:
does » dos (Expandir a Pesquisa)
develop » developed (Expandir a Pesquisa)
dose » dos (Expandir a Pesquisa)
does » dos (Expandir a Pesquisa)
develop » developed (Expandir a Pesquisa)
dose » dos (Expandir a Pesquisa)
201
Por Hasan, Anwarul, Waters, Renae, Roula, Boustany, Dana, Rahbani, Yara, Seif, Alexandre, Toubia, Paul, Arghya
Publicado no Macromol Biosci (2016)
“... constructs are developed in vitro by combining stem cells and biomaterial scaffolds for drug screening...”Publicado no Macromol Biosci (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
202
Por Hershman, Dawn, Calhoun, Elizabeth, Zapert, Kinga, Wade, Shawn, Malin, Jennifer, Barron, Rich
Publicado em 2008
“..., nor do they appear to adequately equip patients to cope with them. Therefore, efforts to improve...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
203
Por López-Abarrategui, Carlos, del Monte-Martínez, Alberto, Reyes-Acosta, Osvaldo, Franco, Octavio L., Otero-González, Anselmo J.
Publicado em 2013
“... bacteria. This molecule is recognized as a sign of bacterial infection, responsible for the development...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
204
Por Sachdeva, Shivangi, Palur, Raghuvamsi V., Sudhakar, Karpagam U., Rathinavelan, Thenmalarchelvi
Publicado no Front Microbiol (2017)
“... and anchorage in relevance to drug and vaccine developments....”Publicado no Front Microbiol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
205
“... medicinal benefits. Several studies investigate its bioactive components as a means to associate them with a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
206
“... for developing new drug targets for precise control of MAO-A activity. Over the last few decades, several...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
207
“... infections in the human host. These pathogens are able to persist inside the host due to the development...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
208
Por Mason, Daniel J., Eastman, Richard T., Lewis, Richard P. I., Stott, Ian P., Guha, Rajarshi, Bender, Andreas
Publicado no Front Pharmacol (2018)
“... malaria infection in humans, and with resistance developing rapidly novel treatment modalities...”Publicado no Front Pharmacol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
209
Por Zhou, Lujia, Chávez-Gutiérrez, Lucia, Bockstael, Katrijn, Sannerud, Ragna, Annaert, Wim, May, Patrick C., Karran, Eric, De Strooper, Bart
Publicado em 2011
“... interesting alternative sites on BACE1 that could become targets for drug development....”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
210
Por Lafaye, Genevieve, Karila, Laurent, Blecha, Lisa, Benyamina, Amine
Publicado no Dialogues Clin Neurosci (2017)
“.... However, their composition and pharmacological properties make them dangerous substances. Cannabis does...”Publicado no Dialogues Clin Neurosci (2017)
Obter o texto integral
Obter o texto integral
Artigo
211
Por Berto-Júnior, Clemilson, de Carvalho, Denise Pires, Soares, Paula, Miranda-Alves, Leandro
Publicado no Front Endocrinol (Lausanne) (2018)
“... (morphologic, biochemical, and pathophysiological studies) and pharmaceutical industry (toxicology and drug...”Publicado no Front Endocrinol (Lausanne) (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
212
“... of the development and spread of drug resistance....”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
213
Por Clergue-Duval, Virgile, Robin, Suzanne, Fortias, Maeva, Dupuy, Gaël, Badin-de-Montjoye, Béatrice, Vorspan, Florence
Publicado no Harm Reduct J (2017)
“... social exclusion, severe material deprivation andopiates use with frequent high-risk drug use and sexual...”Publicado no Harm Reduct J (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
214
“... and, finally, suggest future directions to better inform drug development and public health....”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
215
Por Andreasson, Ulf, Perret-Liaudet, Armand, van Waalwijk van Doorn, Linda J. C., Blennow, Kaj, Chiasserini, Davide, Engelborghs, Sebastiaan, Fladby, Tormod, Genc, Sermin, Kruse, Niels, Kuiperij, H. Bea, Kulic, Luka, Lewczuk, Piotr, Mollenhauer, Brit, Mroczko, Barbara, Parnetti, Lucilla, Vanmechelen, Eugeen, Verbeek, Marcel M., Winblad, Bengt, Zetterberg, Henrik, Koel-Simmelink, Marleen, Teunissen, Charlotte E.
Publicado no Front Neurol (2015)
“... medicine, and also in clinical research and drug development, also for brain disorders, such as Alzheimer’s...”Publicado no Front Neurol (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
216
Por Zinzi, Laura, Capparelli, Elena, Cantore, Mariangela, Contino, Marialessandra, Leopoldo, Marcello, Colabufo, Nicola Antonio
Publicado em 2014
“... ligands have been developed and, among them, Tariquidar has been extensively studied both in vitro...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
217
Por Paul, Steven M., Doherty, James J., Robichaud, Albert J., Belfort, Gabriel M., Chow, Brian Y., Hammond, Rebecca S., Crawford, Devon C., Linsenbardt, Andrew J., Shu, Hong-Jin, Izumi, Yukitoshi, Mennerick, Steven J., Zorumski, Charles F.
Publicado em 2013
“... site that also represents a target for therapeutic drug development....”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
218
Por Abhilash, B., Tripathi, Chakra Dhar, Gogia, Anoop Raj, Meshram, Girish Gulab, Kumar, Manu, Suraj, B.
Publicado no Indian J Crit Care Med (2015)
“... and the nongastrointestinal groups was significant at 2 h (P = 0.015) following drug dosing; while the difference...”Publicado no Indian J Crit Care Med (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
219
Por Li, Yiman, Sun, Licui, Lu, Chunyan, Gong, Ying, Li, Min, Sun, Shujuan
Publicado no Front Cell Infect Microbiol (2018)
“... of drug resistance is a new limitation to successful patient outcomes. Therefore, the development...”Publicado no Front Cell Infect Microbiol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
220
Por Yu. D. Ryzhkova, E. V. Kanareykina, M. R. Atabegashvili, E. V. Konstantinova, M. Yu. Gilyarov
Publicado em 2019-08-01
“... is to the level of current recommendations and whether it is possible to apply them unconditionally in this group...”Publicado em 2019-08-01
Obter o texto integral
Artigo